These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23896470)

  • 1. Pharmacokinetics and pharmacodynamics of once-daily administration of intravenous tobramycin in adult patients with cystic fibrosis hospitalized for an acute pulmonary exacerbation.
    Butterfield JM; Lodise TP; Beegle S; Rosen J; Farkas J; Pai MP
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5175-7. PubMed ID: 23896470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
    Somayaji R; Russell R; Cogen JD; Goss CH; Nick SE; Saavedra MT; Taylor-Cousar JL; Nick JA; Nichols DP
    Ann Am Thorac Soc; 2019 Jul; 16(7):853-860. PubMed ID: 30840835
    [No Abstract]   [Full Text] [Related]  

  • 4. Does Circadian Rhythm Affect the Pharmacokinetics of Once-Daily Tobramycin in Adults With Cystic Fibrosis?
    van Maarseveen EM; van der Meer R; Neef C; Heijerman HGM; Touw DJ
    Ther Drug Monit; 2020 Aug; 42(4):595-599. PubMed ID: 32049889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration.
    Beringer PM; Vinks AA; Jelliffe RW; Shapiro BJ
    Antimicrob Agents Chemother; 2000 Apr; 44(4):809-13. PubMed ID: 10722474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of once and twice daily dosing of intravenous tobramycin in paediatric patients with cystic fibrosis.
    Brigg Turner R; Elbarbry F; Biondo L
    J Chemother; 2016 Aug; 28(4):304-7. PubMed ID: 26430825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.
    Lam W; Tjon J; Seto W; Dekker A; Wong C; Atenafu E; Bitnun A; Waters V; Yau Y; Solomon M; Ratjen F
    J Antimicrob Chemother; 2007 Jun; 59(6):1135-40. PubMed ID: 17446242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualization of tobramycin dosage in patients with cystic fibrosis.
    Hsu MC; Aguila HA; Schmidt VL; Munzenberger PJ; Kauffman RE; Polgar G
    Pediatr Infect Dis; 1984; 3(6):526-9. PubMed ID: 6440126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 6 and 8 hourly tobramycin dosing intervals in treatment of pulmonary exacerbations in cystic fibrosis patients.
    Winnie GB; Cooper JA; Witson J; Cowan RG; Mayer D; Lepow M
    Pediatr Infect Dis J; 1991 May; 10(5):381-6. PubMed ID: 1906161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis.
    Sherwood SJ; Tak C; Bhakta ZN; Packer K; Jacobs H; Liou TG; Young DC
    Pediatr Pulmonol; 2024 Jun; 59(6):1740-1746. PubMed ID: 38501330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients.
    van Koningsbruggen-Rietschel S; Heuer HE; Merkel N; Posselt HG; Staab D; Sieder C; Ziegler J; Krippner F; Rietschel E
    J Antimicrob Chemother; 2016 Mar; 71(3):711-7. PubMed ID: 26626719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.
    Hennig S; Norris R; Kirkpatrick CM
    Br J Clin Pharmacol; 2008 Apr; 65(4):502-10. PubMed ID: 17995972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M; Nazareth D; Walshaw M
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.
    Horrevorts AM; Degener JE; Dzoljic-Danilovic G; Michel MF; Kerrebijn KF; Driessen O; Hermans J
    Chest; 1985 Aug; 88(2):260-4. PubMed ID: 4017681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis.
    Fiel SB
    Chest; 1995 Feb; 107(2 Suppl):61S-64S. PubMed ID: 7842815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
    van Velzen AJ; Bos AC; Touw DJ; Tiddens HA; Heijerman HG; Janssens HM
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):273-80. PubMed ID: 26716357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Area under the curve achievement of once daily tobramycin in children with cystic fibrosis during clinical care.
    Brockmeyer JM; Wise RT; Burgener EB; Milla C; Frymoyer A
    Pediatr Pulmonol; 2020 Dec; 55(12):3343-3350. PubMed ID: 32827334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.